January 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreFebruary 09, 2026
The global single-use bioreactors market, valued at USD 5.38 billion in 2025, is anticipated to reach USD 26.33 billion by 2035, growing at a CAGR of 17.21% over the next decade. In 2024, North America led the single-use bioreactors market (35%), with Asia Pacific set for rapid growth. SUB systems and stirred tank types dominated, while single-use ...
February 09, 2026
According to research projections, the global biosensors market, projected at USD 32.64 billion in 2025, is expected to reach USD 74.76 billion by 2035, growing at a CAGR of 8.64% over the forecast period. In 2024, North America led the biosensors market with a 41% share, while Asia-Pacific is set for the fastest growth. Electrochemical biosensors ...
February 09, 2026
Market insights predict the global medical device testing industry will increase from USD 10.77 billion in 2025 to USD 26.62 billion by 2035, achieving a CAGR of 9.47%. In 2024, Asia-Pacific led the global medical device testing market, while North America is set for the fastest growth ahead. Biocompatibility tests dominated by service, with chemis...
February 09, 2026
Forecasts suggest that the oncology molecular diagnostics market will expand from USD 3.48 billion in 2025 to USD 10.93 billion by 2035, with a CAGR of 12.13% during this period. In 2024, North America led the global oncology molecular diagnostics market, while Asia-Pacific is set for the fastest growth. Breast cancer was the top segment, with live...
February 09, 2026
According to forecasts, the global intranasal corticosteroids market will grow from USD 7.57 billion in 2025 to USD 12.14 billion by 2035, with an expected CAGR of 4.84%. The globally rising prevalence of chronic rhinitis due to the expanding urbanization and industrialization is demanding INCs. North America dominated the market due to its fosteri...
February 09, 2026
According to market projections, the monoclonal antibody for asthma and COPD sector is expected to grow from USD 34.02 billion in 2025 to USD 58.94 billion by 2035, reflecting a CAGR of 5.65%, providing detailed analysis of disease-specific segments, regional distribution (NA, EU, APAC, LA, MEA), manufacturer data, competitive benchmarking, value...
February 09, 2026
The global GMP drug substance market was USD 2.71 billion in 2025 and is projected to reach USD 4.91 billion by 2035 at a CAGR of 6.14%. Key segments include viral vectors, cell-based therapies, oligonucleotides, and biologics. North America leads, with Asia-Pacific growing fastest. The market features top players like AGC Biologics, Catalent, an...
February 09, 2026
Based on our research, the clinical diagnostics market was valued at USD 123.22 billion in 2025 and is projected to reach USD 131.4 billion in 2026, further expanding to USD 234.36 billion by 2035, growing at a CAGR of 6.64% during 2026–2035....
February 09, 2026
According to our projections, the bulk-drug compounding market was valued at USD 12.52 billion in 2025 and reached USD 13.18 billion in 2026, and it is projected to grow to USD 20.87 billion by 2035 at a CAGR of 5.24% during 2026–2035....
February 09, 2026
According to our forecasts, the clinical endpoint adjudication (CEA) market was valued at USD 0.97 billion in 2025 and is projected to grow from USD 1.05 billion in 2026 to USD 2.23 billion by 2035, expanding at a CAGR of 8.66%....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com